du Pré, SaskiaBeckmann, NicolaAlmeida, Mariana CruzSibley, Graham E MLaw, DerekBrand, Alexandra CBirch, MikeRead, Nick DOliver, Jason D2019-02-012019-02-012018-08-01du Pré, S, Beckmann, N, Almeida, M C, Sibley, G E M, Law, D, Brand, A C, Birch, M, Read, N D & Oliver, J D 2018, 'The effect of the novel antifungal drug F901318 (Olorofim) on the growth and viability of Aspergillus fumigatus', Antimicrobial Agents and Chemotherapy, vol. 62, no. 8, e00231-18, pp. 1-11. https://doi.org/10.1128/AAC.00231-180066-4804http://hdl.handle.net/2164/11851We thank our colleagues at F2G Ltd. for their support in this work, as well as the Manchester Fungal Infection Group at the University of Manchester. We also thank Gillian Milne and the Microscopy and Histology Core Facility at the Medical Research Council Centre for Medical Mycology at the University of Aberdeen for their assistance with TEM. We also thank John Rex for critical reading of the manuscript. The Microscopy and Histology Core Facility at the Medical Research Council Centre for Medical Mycology at the University of Aberdeen is supported by grant number MR/N006364/1. S.D.P. and M.C.A. are supported by the European Marie Curie ITN FungiBrain grant PITN-GA-2013-607963. S.D.P. was the primary author and performed the live-cell imaging microscopy, TEM, viability staining, and the analysis of the data. N.B. performed the postexposure effect assays. M.C.A. assisted with TEM. G.E.M.S. designed F901318. N.B., A.C.B., D.L., M.B., N.D.R., and J.D.O. provided guidance and assistance during this project and in the preparation of the manuscript.111638520engAspergillus fumigatusF901318antifungal agentsaspergillosisfilamentous fungiolorofimorotomideQR MicrobiologyR MedicineMedical Research Council (MRC)MR/N006364/1European CommissionPITN-GA-2013-607963QRRJournal article10.1128/AAC.00231-18628